These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29248061)

  • 1. Does Part D abet advantageous selection in Medicare Advantage?
    Han T; Lavetti K
    J Health Econ; 2017 Dec; 56():368-382. PubMed ID: 29248061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
    Elliott MN; Landon BE; Zaslavsky AM; Edwards C; Orr N; Beckett MK; Mallett J; Cleary PD
    Health Aff (Millwood); 2016 Mar; 35(3):456-63. PubMed ID: 26953300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program.
    Brown J; Duggan M; Kuziemko I; Woolston W
    Am Econ Rev; 2014 Oct; 104(10):3335-64. PubMed ID: 29533567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug plan design incentives among Medicare prescription drug plans.
    Huskamp HA; Keating NL; Dalton JB; Chernew ME; Newhouse JP
    Am J Manag Care; 2014 Jul; 20(7):562. PubMed ID: 25295402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of coding intensity in Medicare Advantage on plan benefits and finances.
    Jacobs PD; Kronick R
    Health Serv Res; 2021 Apr; 56(2):178-187. PubMed ID: 33165932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries.
    Maust DT; Lin LA; Goldstick JE; Haffajee RL; Brownlee R; Bohnert ASB
    JAMA Netw Open; 2020 Apr; 3(4):e202051. PubMed ID: 32242907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting What We Pay For: How Do Risk-Based Payments to Medicare Advantage Plans Compare with Alternative Measures of Beneficiary Health Risk?
    Jacobs PD; Kronick R
    Health Serv Res; 2018 Dec; 53(6):4997-5015. PubMed ID: 29790162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Medicare plan choices: are beneficiaries more influenced by premiums or benefits?
    Jacobs PD; Buntin MB
    Am J Manag Care; 2015 Jul; 21(7):498-504. PubMed ID: 26247740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary disenrollment from Medicare advantage plans: valuable signals of market performance.
    Mobley LR; McCormack LA; Wang J; Squire C; Kenyon A; Lynch JT; Heller A
    Am J Manag Care; 2007 Dec; 13(12):677-84. PubMed ID: 18069911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Sep; 76(170):54600-35. PubMed ID: 21894660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilar formulary placement in Medicare Part D prescription drug plans: A case study of infliximab.
    Socal MP; Ezebilo I; Bai G; Anderson GF
    Am J Health Syst Pharm; 2021 Jan; 78(3):216-221. PubMed ID: 33289035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The High Coverage of Dental, Vision, and Hearing Benefits Among Medicare Advantage Enrollees.
    Willink A
    Inquiry; 2019; 56():46958019861554. PubMed ID: 31271082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Program: Changes to the Medicare Claims and Entitlement, Medicare Advantage Organization Determination, and Medicare Prescription Drug Coverage Determination Appeals Procedures. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2017 Jan; 82(10):4974-5140. PubMed ID: 28102985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse selection in the Medicare prescription drug program.
    Riley GF; Levy JM; Montgomery MA
    Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.
    Hsu J; Fung V; Huang J; Price M; Brand R; Hui R; Fireman B; Dow WH; Bertko J; Newhouse JP
    Health Aff (Millwood); 2010 Dec; 29(12):2335-43. PubMed ID: 21030394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Medicare managed care market withdrawal on beneficiaries.
    Booske BC; Lynch J; Riley G
    Health Care Financ Rev; 2002; 24(1):95-115. PubMed ID: 12545601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an out-of-pocket maximum in Medicare Part D.
    Parasrampuria S; Anderson GF
    Am J Manag Care; 2022 Feb; 28(2):e55-e62. PubMed ID: 35139297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.